13th May 2019
ARCA biopharma Announces Submission of Patent Application to U.S. Patent and Trademark Office Covering Treatment of Atrial Fibrillation in Patients With Heart Failure GlobeNewswire
Similar Applications to Be Filed in Europe, Canada, Japan and China.
